Most Recent
Coal mining firm TerraCom has lost its Full Court bid to shield a PricewaterhouseCoopers report from ASIC, on appeal from a judgment which found the regulator could view the report because of public statements made by the company.
Two insurers for Dixon Advisory have argued they should not have to disclose policies that could respond to mammoth claims in a class action against the collapsed financial services firm estimated to be worth $278 million and $463 million.
Wilsons Advisory and Stockbroking has dodged a claim by rival Elston Private Wealth over a veteran employee who jumped ship with confidential information.
Three insurers for builder Icon are planning to test the reasonableness of a structural engineer's defence costs in a now settled class action brought by apartment owners in Sydney's ill-fated Opal Tower.
The protective scope of whistleblower laws will be tested in a $13 million suit brought by a former Greenwoods & Herbert Smith Freehills partner allegedly sacked for complaining about the tax avoidance strategy of construction giant Lendlease, the advisory firm's biggest client.
The maker of Finish dishwashing products has had two of its trade marks struck from the register after losing an intellectual property suit against an emerging rival.
Clive Palmer’s Queensland Nickel refinery has lost its appeal of a decision ordering it pay $26.6 million for natural gas charges owed after a court rejected claims it did not need to repay the money because pipeline owners had breached their duties.
London firm Mishcon de Reya faces a lawsuit alleging the firm knowingly assisted a founding partner of Lipman Karas to breach his duties when it reached an agreement to open a Hong Kong office.
A judge has questioned how the government can enforce a “restrictive” undertaking with a former member of the Australian Defence Force who will give key evidence in a class action alleging the Commonwealth contaminated Indigenous land with toxic firefighting foam.
Pharmaceutical ingredient producer Alkaloids of Australia is facing a maximum $30 million penalty but has argued it should pay less than $1 million after pleading guilty to cartel conduct over the supply of a key chemical found in generic stomach cramp drugs.